Dr. Mark Harber, M.D

NPI: 1508961673
Total Payments
$1,029
2020 Payments
$236.21
Companies
5
Transactions
16
Medicare Patients
125
Medicare Billing
$10,676

Payment Breakdown by Category

Food & Beverage$1,029 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,029 16 100.0%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $785.05 11 $0 (2020)
Janssen Pharmaceuticals, Inc $196.51 2 $0 (2019)
AbbVie, Inc. $20.52 1 $0 (2019)
Grifols USA, LLC $13.73 1 $0 (2019)
Depomed, Inc. $12.86 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2020 $236.21 3 AstraZeneca Pharmaceuticals LP ($236.21)
2019 $157.43 3 Janssen Pharmaceuticals, Inc ($123.18)
2018 $356.87 6 AstraZeneca Pharmaceuticals LP ($283.54)
2017 $278.16 4 AstraZeneca Pharmaceuticals LP ($265.30)

All Payment Transactions

16 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
09/30/2020 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $125.00 General
Category: Cardiovascular and Metabolism
07/23/2020 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $99.87 General
Category: Cardiovascular and Metabolism
07/22/2020 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $11.34 General
Category: Cardiovascular and Metabolism
06/05/2019 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $123.18 General
Category: Cardiovascular & Metabolism
05/01/2019 Grifols USA, LLC Prolastin-C Liquid (Biological) Food and Beverage In-kind items and services $13.73 General
Category: Pulmonology
02/15/2019 AbbVie, Inc. Food and Beverage In-kind items and services $20.52 General
12/05/2018 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $73.33 General
Category: Cardiovascular & Metabolism
12/04/2018 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $124.99 General
Category: Cardiovascular and Metabolism
10/19/2018 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $12.25 General
Category: Cardiovascular and Metabolism
05/18/2018 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $12.85 General
Category: Cardiovascular and Metabolism
02/16/2018 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $8.31 General
Category: Cardiovascular and Metabolism
02/01/2018 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $125.14 General
Category: Cardiovascular and Metabolism
09/07/2017 AstraZeneca Pharmaceuticals LP BYDUREON (Drug) Food and Beverage In-kind items and services $124.96 General
Category: Cardiovascular and Metabolism
06/05/2017 Depomed, Inc. Nucynta (Drug) Food and Beverage In-kind items and services $12.86 General
Category: Pain
05/16/2017 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $15.35 General
Category: Cardiovascular and Metabolism
05/11/2017 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $124.99 General
Category: Cardiovascular and Metabolism

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2021 1 35 42 $3,150 $1,839
2020 3 90 149 $13,150 $8,837
Total Patients
125
Total Services
191
Medicare Billing
$10,676
Procedure Codes
4

All Medicare Procedures & Services

4 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 35 42 $3,150 $1,839 58.4%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 54 107 $8,025 $5,242 65.3%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 22 28 $3,080 $1,998 64.9%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2020 14 14 $2,045 $1,596 78.1%

About Dr. Mark Harber, M.D

Dr. Mark Harber, M.D is a Family Medicine healthcare provider based in Niceville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508961673.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Harber, M.D has received a total of $1,029 in payments from pharmaceutical and medical device companies, with $236.21 received in 2020. These payments were reported across 16 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($1,029).

As a Medicare-enrolled provider, Harber has provided services to 125 Medicare beneficiaries, totaling 191 services with total Medicare billing of $10,676. Data is available for 2 years (2020–2021), covering 4 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Niceville, FL
  • Active Since 09/14/2006
  • Last Updated 11/04/2012
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • NPI Number 1508961673

Products in Payments

  • FARXIGA (Drug) $660.09
  • XARELTO (Drug) $196.51
  • BYDUREON (Drug) $124.96
  • Prolastin-C Liquid (Biological) $13.73
  • Nucynta (Drug) $12.86

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Niceville